FIELD: immunotherapy.
SUBSTANCE: invention relates to immunotherapy based on the use of antigens, more specifically to cancer immunotherapy. In particular, the invention relates to antigenic peptides similar in amino acid composition to fragments of human tumor antigens, but different from them. The invention also relates to immunogenic compounds, cells and pharmaceutical compositions containing such antigenic peptides and nucleic acids encoding such antigenic peptides.
EFFECT: invention provides alternative methods of treating cancer that will overcome existing limitations.
53 cl, 13 dwg, 10 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDES AND THEIR USE IN TREATMENT OF DISEASES, DISORDERS OR CONDITIONS ASSOCIATED WITH MUTANT p53 | 2017 |
|
RU2762089C2 |
| ANTIBODIES AGAINST A5 REPRESENTATIVE OF 19 FAMILY WITH SIMILARITY OF SEQUENCES AND THEIR APPLICATION METHOD | 2019 |
|
RU2785436C2 |
| NON-GENETIC MODIFICATION OF ENVELOPED VIRUSES | 2017 |
|
RU2760521C2 |
| ANTIBODIES AGAINST CXCR2 AND THEIR USE | 2019 |
|
RU2807067C2 |
| ANTI-C10orf54 ANTIBODIES AND APPLICATIONS THEREOF | 2015 |
|
RU2819627C1 |
| ANTIBODIES AGAINST PD-L1 AND THEIR OPTIONS | 2017 |
|
RU2770590C2 |
| POLYPEPTIDE COMPRISING ANTIGEN-BINDING DOMAIN AND TRANSPORT SEGMENT | 2018 |
|
RU2815452C2 |
| ANTI-PVRIG ANTIBODIES AND METHODS OF USING | 2016 |
|
RU2732042C2 |
| ANTIBODY AGENTS SPECIFIC TO HUMAN CD19, AND THEIR APPLICATIONS | 2016 |
|
RU2773317C2 |
| ANTIBODIES DIRECTED TO CD127 | 2015 |
|
RU2734076C2 |
